Application study on smecta plus befuxin combined with exposure therapy in neonatal hip redness
Zhang Xiaoli1, Mu Feifei2
1 School of Nursing, Binzhou Medical University, Binzhou 256603, China; 2 School of Public Health and Management, Yantai Affiliated Hospital of Binzhou Medical University
Abstract：Objective To explore the therapeutic effect of befuxin plus smecta combined with exposure therapy on neonatal hip redness. Methods A total of 46 cases of buttock redness occurred in the neonatal children admitted to our hospital, which were divided into the control group and the experiment group according to the order of admission. Children in the control group were treated with smecta, and those in the experiment group were treated with smecta plus befuxin combined with exposure therapy. Results The apparent efficiency of the experiment group was 86.96% and the effective rate was 13.04%, while the apparent efficiency of the control group was 60.87%, and the effective rate was 30.43%. The therapeutic effect of the experiment group was better than that of the control group (P<0.05). The healing time of the experiment group [(102.29 + + 61.34)h] was less than that of the control group [(142.52 + 60.23)h], and the comparison of healing time between the two groups was statistically significant (P<0.05). Conclusion Befuxin plus smecta combined with exposure therapy has a significant effect in the treatment of newborn buttock redness. It can effectively shorten the healing time of skin rash and is safe and reliable.
张晓丽, 牟飞飞. 思密达与贝复新联合暴露疗法在新生儿臀红中应用研究[J]. 中国医院统计, 2018, 25(4): 263-264.
Zhang Xiaoli, Mu Feifei. Application study on smecta plus befuxin combined with exposure therapy in neonatal hip redness. journal1, 2018, 25(4): 263-264.
